Eyelash Extensions Under Scrutiny - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Eyelash Extensions Under Scrutiny

  • September 13, 2026

  • 3 min

Share

Clinical Scorecard: Eyelash Extensions Under Scrutiny

At a Glance

CategoryDetail
ConditionEyelash Extension Use
Key MechanismsDemodex folliculorum infestation, ocular irritation, meibomian gland dysfunction
Target PopulationYoung women aged 16–28 years
Care SettingOphthalmology

Key Highlights

  • 47.6% of eyelash extension users reported discomfort, redness, tearing, or itching.
  • 85% of women with 10+ eyelash extension procedures showed signs of meibomian gland dysfunction.
  • 24 out of 25 examined eyelash samples contained Demodex folliculorum mites.
  • Symptoms consistent with mite-associated inflammation were observed in 18 participants.
  • Appropriate eyelid hygiene and clinical assessment are recommended for persistent irritation.

Guideline-Based Recommendations

Diagnosis

  • Consider demodectic blepharitis in patients with chronic eyelid irritation who use eyelash extensions.

Management

  • Antiparasitic treatment may be considered for confirmed Demodex infestation.

Monitoring & Follow-up

  • Assess for symptoms of ocular irritation and meibomian gland health in extension users.

Risks

  • Potential ocular health risks associated with repeated eyelash extension procedures.

Patient & Prescribing Data

Women aged 16–28 years who use eyelash extensions.

Emphasize eyelid hygiene and awareness of symptoms related to eyelash extensions.

Clinical Best Practices

  • Educate clients about potential ocular health risks of eyelash extensions.
  • Encourage regular eyelid hygiene practices among extension users.

Related Resources & Content

Original Source(s)

Related Content